ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc.
Provided By PR Newswire
Last update: Mar 11, 2025
NEW YORK, March 11, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by 2seventy bio, Inc. (NASDAQ: TSVT) and its board of directors concerning the proposed acquisition of the company by Bristol Myers Squibb (NYSE: BMY). Stockholders will receive $5.00 for each share of 2seventy bio stock that they hold. The transaction is valued at approximately $286 million and is expected to close in the second quarter of 2025.
Read more at prnewswire.com48.28
+0.43 (+0.9%)
Find more stocks in the Stock Screener
BMY Latest News and Analysis
12 hours ago - ChartmillBRISTOL-MYERS SQUIBB CO (NYSE:BMY) – A Potentially Undervalued Dividend StockBRISTOL-MYERS SQUIBB (NYSE:BMY) offers a high dividend yield, strong profitability, and an undervalued stock price, making it a candidate for value investors.
16 days ago - ChartmillBRISTOL-MYERS SQUIBB CO (NYSE:BMY) - A High-Yield Dividend Stock Worth ConsideringBRISTOL-MYERS SQUIBB CO (NYSE:BMY) offers a high 5.29% dividend yield with strong growth and profitability, making it a solid pick for income investors.
16 days ago - ChartmillWhat's going on in today's session: S&P500 moversUncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Thursday.
17 days ago - ChartmillStay informed with the top movers within the S&P500 index on Wednesday.Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.
19 days ago - ChartmillMarket Monitor News May 12 ( NRG Energy, Amazon, Meta Platforms UP - CVS Health DOWN)Wall Street Surges on Temporary Trade Truce Between US and China
